Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), Alcatel Lucent SA (ADR) (ALU): 4 Stocks On The Verge Of Breaking Out!

Page 1 of 2

Rite Aid Corporation (NYSE:RAD) has been my favorite stock for the better part of the last year. I first began covering the stock when it was at $1.00 back in December 2012, and then quickly purchased a large position of the company after it reported Q3 earnings, at $1.23.

Rite Aid had gone six years without posting a profit, and then all of a sudden posted two phenomenal and profitable quarters in Q3 and Q4. The company is now expecting full-year profits between $45 million and $200 million.

Rite Aid Corporation (NYSE:RAD)

Rite Aid Corporation (NYSE:RAD) has undergone a very long restructuring program – but the “real” operational improvements are due to the generic cliff in healthcare. For pharmacies, generic drugs pay higher margins, and in 2012 there were many companies with blockbuster drugs that lost patents; more are expected in 2013.

Fortunately, Rite Aid is still cheap. Its profit margin of 0.47% is one-seventh of CVS Caremark Corporation (NYSE:CVS) and its price/sales ratio of 0.10 is about one-sixth of Walgreen Company (NYSE:WAG). As a result, the stock is now climbing higher as fast as possible.

During a four week period starting April 25, Rite Aid fluctuated between $2.50 and $2.65, before breaking out over $3.00. Currently, it’s doing the same, trending between $2.85 and $3.00. Now that it’s priced at $2.94 it will be interesting to see if it exceeds 52-week highs of $3.04. If so, the stock could run significantly higher – after all, it is a very cheap stock!

An Under-The-Radar Uptrend

After five years of almost continuous losses, shares of Alcatel Lucent SA (ADR) (NYSE:ALU) are trending back to levels not seen since early February. Back in late 2012, its trend higher was due to news of its massive restructuring program. The company completed financing with Goldman Sachs and then vowed to monetize its patents and divest all of its ineffective segments.

Alcatel Lucent SA (ADR) (NYSE:ALU) is trading at $1.68, making it a $3.8 billion company with almost $19 billion in annual revenue. Its price/sales ratio of 0.20 is almost unheard of in the telecom equipment industry, a space where most companies trade at 1.2 to 2.0 times sales.

At $1.68 Alcatel-Lucent is just $0.11 from its current 52-week high. Alcatel has seen a 23.5% gain in the month of May – greatly outperforming the S&P 500 – despite underperforming the market in recent months. Thus, due to its trend, Alcatel Lucent SA (ADR) (NYSE:ALU) is definitely a stock to watch, one that could breakout significantly higher. The stock is simply too cheap and is too close to its current high.

Resiliency Proof Of Potential Breakout

During Apple Inc. (NASDAQ:AAPL)‘s seven month $300 billion market cap loss, we saw one pattern in particular repeat itself time-after-time: The stock always went through periods where it would bounce significantly higher off its lows.

In November, it went from $525 to $590 – it went from $510 to $560 to start 2013 – then, $440 to $480 in February. These trends always had one thing in common: the lows were always lower than the previous low, and even after trending higher, these lows were always re-tested.

When we begin to talk about prices and trends I know it can get a little confusing – but the point I am trying to make is that Apple Inc. (NASDAQ:AAPL) tried to retest lows of $385 in mid-May – yet was unsuccessful. Since falling to $425 in mid-May, Apple has trended higher and is currently at $450.

The company recently increased its share buyback program to $60 billion over the next three years, and rest assured, the company is buying like crazy while the stock is this cheap. Moreover, it has a yield of 2.70%, and I believe that because prior lows of $385 were not reached in mid-May that Apple Inc. (NASDAQ:AAPL) will continue to trade higher and breakout into a higher level.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!